Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state

Yarden Katz, Feifei Li, Nicole Lambert, Ethan S. Sokol, Wai Leong Tam, Albert W. Cheng, Edoardo M. Airoldi, Christopher J. Lengner, Piyush B. Gupta, Zhengquan Yu, Rudolf Jaenisch, Christopher B. Burge

TL;DR

Musashi (Msi) proteins, RNA-binding proteins typically found in stem cells, are frequently overexpressed in human cancers and associated with an epithelial cell state. This study reveals that Msi proteins act as post-transcriptional regulators, controlling both the translation of key genes and the splicing of RNA transcripts to maintain this epithelial identity and suppress the epithelial-to-mesenchymal transition (EMT).

What Problem Does This Paper Address?

Cellular identity, particularly the distinction between epithelial and mesenchymal states, is crucial for normal development and is often hijacked during cancer progression, enabling metastasis. While transcription factors have been extensively studied as drivers of these state transitions (like EMT), the role of RNA-binding proteins (RBPs) in orchestrating these complex changes at the post-transcriptional level is less understood. Specifically, the conserved Musashi (Msi) family of RBPs are known to be expressed in stem and progenitor cells but their precise function in maintaining cell states, especially the epithelial state, and their impact on EMT in mammals remained unclear. This paper aims to elucidate the molecular mechanisms by which Msi proteins contribute to cell state regulation, focusing on their role in maintaining an epithelial identity and their dysregulation in cancer.

Methods

The researchers employed a multi-pronged approach:

  • Genomic and Transcriptomic Analysis: They analyzed RNA-sequencing (RNA-Seq) data from The Cancer Genome Atlas (TCGA) to assess Msi gene expression and mutation profiles across various human cancers. They also performed unsupervised hierarchical clustering of breast cancer samples to correlate Msi expression with known cancer subtypes.
  • Cellular and Molecular Assays:
    • RNA-Seq and Ribosome Profiling (Ribo-Seq): These techniques were used to comprehensively analyze changes in both mRNA levels and their translation efficiency upon Msi overexpression or depletion in neural stem cells (NSCs). Ribo-Seq specifically measures ribosome occupancy on mRNAs, providing insights into translational control.
  • Immunofluorescence and Immunohistochemistry: These techniques were used to visualize the localization of Msi proteins within cells and tissues, and to assess the expression of epithelial (e.g., E-cadherin) and mesenchymal markers.
  • RNA Bind-n-Seq (RBNS): This method was used to determine the sequence-specific RNA binding preferences of Msi proteins, identifying potential target RNA motifs.
  • Gel-Shift Assays and Luciferase Reporter Assays: These were employed to validate direct binding of Msi proteins to target RNAs (specifically Jagged1) and to confirm Msi's effect on protein translation.
  • In vitro models of EMT: Breast cancer cell lines and mammary gland explants were used to study the functional consequences of Msi manipulation on EMT processes and cell morphology.
  • Genetic Systems: Inducible overexpression and conditional knockout systems in mouse neural stem cells (NSCs) were crucial for dissecting the molecular functions of Msi proteins.

Datasets

  • The Cancer Genome Atlas (TCGA): RNA-Seq data from various human cancer types (breast, lung, prostate, kidney, thyroid) and matched tumor-control pairs were utilized to analyze Msi gene expression and mutation profiles.
  • Publicly available RNA-Seq datasets: Breast cancer cell line RNA-Seq data were used for comparative analysis.
  • Mouse mammary gland RNA-Seq data: Data from purified luminal and basal cells were used to assess Msi expression in vivo.

Key Insights and Ideas

  • Msi as an "Epithelial Identity" Marker: The consistent overexpression of Msi in epithelial-rich tumors and cell lines, coupled with its downregulation upon EMT, strongly suggests Msi proteins are key players in maintaining epithelial cell identity.
  • Dual Post-Transcriptional Control: Msi proteins don't just regulate one aspect of gene expression; they influence both mRNA translation and alternative splicing, providing a robust mechanism for cell state maintenance.
  • Jagged1 as a Key Repressed Target: The repression of Jagged1 translation by Msi is particularly significant, as Jagged1 is a known promoter of EMT. This suggests Msi acts, in part, by directly counteracting pro-EMT signaling pathways.
  • Conserved Function Across Tissues and Species: The observed roles of Msi in maintaining epithelial identity and suppressing EMT in both neural stem cells and mammary gland tissues, and the correlation between mouse and human data, point to a conserved, fundamental function.

Key Results

  • Msi Overexpression in Cancer: Msi1 and Msi2 genes are frequently overexpressed in breast, lung, and prostate cancers, while rarely mutated, suggesting an oncogenic or tumor-promoting role.
  • Msi and Epithelial State: Msi expression is strongly associated with the epithelial-luminal cell state in breast cancer, being higher in luminal tumors and cell lines compared to basal/mesenchymal ones.
  • EMT Inhibition: Knockdown of Msi in epithelial breast cancer cells led to a loss of epithelial markers and a gain of mesenchymal characteristics, promoting EMT. Conversely, Msi overexpression in mesenchymal cells suppressed EMT markers and cell migration.
  • Jagged1 Translation Repression: Msi proteins directly bind to the 3' UTR of Jagged1 mRNA and repress its translation, thereby dampening a key EMT inducer.
  • Splicing Regulation: Msi overexpression and depletion significantly altered alternative splicing patterns in neural stem cells, promoting an "epithelial splicing program" that was conserved in human breast cancer cell lines.
  • In Vivo Mammary Gland Phenotype: Ectopic Msi2 expression in the basal layer of the mouse mammary gland led to an expanded luminal cell layer, defective ductal branching, and suppressed EMT markers, reinforcing its role in maintaining epithelial identity in vivo.

Limitations and Future Work

  • Mechanism of Splicing Regulation: While Msi overexpression affects splicing, the authors acknowledge that Msi proteins are predominantly cytoplasmic, suggesting splicing changes are likely indirect, possibly mediated by Msi's translational regulation of splicing factors. Further investigation into these indirect mechanisms is warranted.
  • Context-Dependent Migration Effects: The observed effect of Msi on cell migration was context-dependent, with significant inhibition in LM2 cells but not in MDAMB231 or SUM159 cells. Understanding the cellular factors that dictate this context-specificity is an area for future research.
  • Broader Tissue Roles: The study focused on neural and mammary tissues. The authors hypothesize Msi might be a general regulator of epithelial stem cells across various tissues, suggesting future studies should explore its role in other stem cell compartments and their associated cancers.
  • Kidney Cancer Findings: The downregulation and mutation of Msi in kidney cancer present an interesting counterpoint, suggesting a potential tumor-suppressive role in specific contexts, which warrants further investigation.

Summary updated

Abstract

The conserved Musashi (Msi) family of RNA binding proteins are expressed in stem/progenitor and cancer cells, but generally absent from differentiated cells, consistent with a role in cell state regulation. We found that Msi genes are rarely mutated but frequently overexpressed in human cancers and are associated with an epithelial-luminal cell state. Using ribosome profiling and RNA-seq analysis, we found that Msi proteins regulate translation of genes implicated in epithelial cell biology and epithelial-to-mesenchymal transition (EMT), and promote an epithelial splicing pattern. Overexpression of Msi proteins inhibited the translation of Jagged1, a factor required for EMT, and repressed EMT in cell culture and in mammary gland in vivo. Knockdown of Msis in epithelial cancer cells promoted loss of epithelial identity. Our results show that mammalian Msi proteins contribute to an epithelial gene expression program in neural and mammary cell types.
BibTeX
@inproceedings{katz2014musashi,
  author = {Yarden Katz and Feifei Li and Nicole Lambert and Ethan S. Sokol and Wai Leong Tam and Albert W. Cheng and Edoardo M. Airoldi and Christopher J. Lengner and Piyush B. Gupta and Zhengquan Yu and Rudolf Jaenisch and Christopher B. Burge},
  title = {{Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state}},
  booktitle = {eLife},
  year = {2014},
  doi = {10.7554/elife.03915},
}
Figure